BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Business

  Nuvig Launches with $47M to Restore Homeostasis to Autoimmunity

  Nuvig plans to use its funding to advance its lead molecule, complete some pre-IND enabling studies and move the molecule to the clinic to begin Phase I studies.

  May 11, 2022

   · 

  2 min read

   · 

  Hayley Shasteen
• 

  Drug Development

  Roche NSCLC Data Doesn’t Bode Well for Anti-TIGIT Immunotherapies

  Genentech (Roche) reported Wednesday that its Phase III SKYSCRAPER-01 trial failed to meet its co-primary endpoint of progression-free survival (PFS).

  May 11, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Policy

  Congressional Report Claims Emergent Mishap Destroyed 400 Million Doses of J&J Vaccine

  An investigation conducted by the U.S. House of Representatives shows Emergent was forced to destroy nearly 400 million doses of the vaccine. The company disputes the report’s claim.

  May 11, 2022

   · 

  3 min read

   · 

  Alex Keown
• 

  Policy

  New Moderna CFO Abruptly Departs Over Investigation at Former Company

  Less than one month after he was appointed as chief financial officer of Moderna, Jorge Gomez abruptly departed the company due to an ongoing investigation at his former company.

  May 11, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Takeda Drops One Hunter Syndrome Therapeutic, Puts Faith in Another

  In its financial results for 2021, Takeda announced that it has decided to discontinue the development of TAK-609, a therapeutic for Hunter Syndrome.

  May 11, 2022

   · 

  3 min read

   · 

  Hayley Shasteen
• 

  Genetown

  Live Forever or Die Trying: The Latest Research on Anti-Aging

  There is always a fair amount of interest in anti-aging potential treatments, with an almost cyclical round of investment in the area. Here’s a look at some new research into aging.

  May 11, 2022

   · 

  4 min read

   · 

  Mark Terry
• 

  Policy

  Cell and Gene Therapy Tackles COVID-19, Potency Assays and Access at ISCT

  With regulatory approvals beginning to break through, attendees at ISCT’s annual meeting set out along the translational pathway. Organizers shared their findings with BioSpace.

  May 11, 2022

   · 

  6 min read

   · 

  Heather McKenzie
• 

  Business

  AstraZeneca, Sanofi’s Positive RSV Data Shows 80% Reduction in Infants

  AstraZeneca and Sanofi’s Phase-III and Phase-IIb clinical trials investigating the efficacy of nirsevimab shows 79.5% efficacy in the prevention of lower respiratory tract infections.

  May 11, 2022

   · 

  2 min read

   · 

  Jazmine Colatriano M.S.
• 

  Business

  FDA Approves Lilly and Incyte’s Olumiant For Hospitalized COVID-19 Patients

  The FDA has given approval for the commercialization of Eli Lilly and Company and Incyte’s Olumiant, setting a precedent for upcoming COVID-19 treatments.

  May 11, 2022

   · 

  2 min read

   · 

  Jazmine Colatriano
• 

  Policy

  Former CFO of Gilead’s Immunomedics Indicted for Fraud, Insider Trading (Updated)

  Usama Malik, the former chief financial officer of Immunomedics, has been indicted for insider trading, five months after the U.S. Securities and Exchange Commission leveled charges.

  May 11, 2022

   · 

  3 min read

   · 

  Alex Keown